Santos
Alonso Alegre
Instituto de Investigación Sanitaria Biobizkaia
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biobizkaia (14)
2024
-
IPCC2023: Looking for translational opportunities by persevering in basic pigment cell research
Pigment Cell and Melanoma Research, Vol. 37, Núm. 5, pp. 546-554
2023
-
A Universal Antigen-Ranking Method to Design Personalized Vaccines Targeting Neoantigens against Melanoma
Life, Vol. 13, Núm. 1
-
Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design
International Journal of Molecular Sciences, Vol. 24, Núm. 10
-
Melanoma Clinical Decision Support System: An Artificial Intelligence-Based Tool to Diagnose and Predict Disease Outcome in Early-Stage Melanoma Patients
Cancers, Vol. 15, Núm. 7
-
Pirin is a prognostic marker of human melanoma that dampens the proliferation of malignant cells by downregulating JARID1B/KDM5B expression
Scientific Reports, Vol. 13, Núm. 1
2022
-
Association of TYR SNP rs1042602 with Melanoma Risk and Prognosis
Life, Vol. 12, Núm. 12
-
First computational design using lambda-superstrings and in vivo validation of SARS-CoV-2 vaccine
Scientific Reports, Vol. 12, Núm. 1
-
MGRN1 as a Phenotypic Determinant of Human Melanoma Cells and a Potential Biomarker
Life, Vol. 12, Núm. 8
2021
-
shinyCurves, a shiny web application to analyse multisource qPCR amplification data: a COVID-19 case study
BMC Bioinformatics, Vol. 22, Núm. 1
2020
-
BRAF V600E mutational load as a prognosis biomarker in malignant melanoma
PLoS ONE, Vol. 15, Núm. 3
-
RKIP regulates differentiation-related features in melanocytic cells
Cancers, Vol. 12, Núm. 6, pp. 1-22
2016
-
Sex-specific genetic effects associated with pigmentation, sensitivity to sunlight, and melanoma in a population of Spanish origin
Biology of Sex Differences, Vol. 7, Núm. 1